These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28038684)

  • 1. LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells.
    Oliveira-Bravo M; Sangiorgi BB; Schiavinato JL; Carvalho JL; Covas DT; Panepucci RA; Neves FA; Franco OL; Pereira RW; Saldanha-Araujo F
    Stem Cell Res Ther; 2016 Dec; 7(1):189. PubMed ID: 28038684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LL-37 stimulates the functions of adipose-derived stromal/stem cells via early growth response 1 and the MAPK pathway.
    Yang Y; Choi H; Seon M; Cho D; Bang SI
    Stem Cell Res Ther; 2016 Apr; 7(1):58. PubMed ID: 27095351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
    Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A
    Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
    Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
    J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4
    Zhang A; Xiong Y; Xu F; Wang Z; Ma J; Zhao N; Hu T; Yi J; Zhou Y; Luan X
    Cell Immunol; 2020 Jun; 352():104113. PubMed ID: 32331794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells.
    Abomaray FM; Al Jumah MA; Kalionis B; AlAskar AS; Al Harthy S; Jawdat D; Al Khaldi A; Alkushi A; Knawy BA; Abumaree MH
    Stem Cell Rev Rep; 2015 Jun; 11(3):423-41. PubMed ID: 25287760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ.
    Kim DS; Jang IK; Lee MW; Ko YJ; Lee DH; Lee JW; Sung KW; Koo HH; Yoo KH
    EBioMedicine; 2018 Feb; 28():261-273. PubMed ID: 29366627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ enhances the immunosuppressive ability of canine bone marrow-derived mesenchymal stem cells by activating the TLR3-dependent IDO/kynurenine pathway.
    Deng J; Li D; Huang X; Li W; Zhao F; Gu C; Shen L; Cao S; Ren Z; Zuo Z; Deng J; Yu S
    Mol Biol Rep; 2022 Sep; 49(9):8337-8347. PubMed ID: 35690960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
    Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
    Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function.
    Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN
    Front Immunol; 2018; 9():2538. PubMed ID: 30473695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Immunosuppressive Potential of INF-γ Licensed Adipose Mesenchymal Stem Cells, Their Secretome and Extracellular Vesicles.
    Serejo TRT; Silva-Carvalho AÉ; Braga LDCF; Neves FAR; Pereira RW; Carvalho JL; Saldanha-Araujo F
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.
    Jones BJ; Brooke G; Atkinson K; McTaggart SJ
    Placenta; 2007; 28(11-12):1174-81. PubMed ID: 17714779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.
    Coffelt SB; Marini FC; Watson K; Zwezdaryk KJ; Dembinski JL; LaMarca HL; Tomchuck SL; Honer zu Bentrup K; Danka ES; Henkle SL; Scandurro AB
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3806-11. PubMed ID: 19234121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of indoleamine 2, 3-dioxygenase (IDO) silencing on immunomodulatory function and cancer-promoting characteristic of adipose-derived mesenchymal stem cells (ASCs).
    Heidari F; Razmkhah M; Razban V; Erfani N
    Cell Biol Int; 2021 Dec; 45(12):2544-2556. PubMed ID: 34498786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
    Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
    Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts.
    Into T; Inomata M; Shibata K; Murakami Y
    Cell Immunol; 2010; 264(1):104-9. PubMed ID: 20570250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LL-37 inhibits LPS-induced inflammation and stimulates the osteogenic differentiation of BMSCs via P2X7 receptor and MAPK signaling pathway.
    Yu X; Quan J; Long W; Chen H; Wang R; Guo J; Lin X; Mai S
    Exp Cell Res; 2018 Nov; 372(2):178-187. PubMed ID: 30287143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placenta derived mesenchymal stromal cells alleviate GVHD by promoting the generation of GSH and GST in PD-1
    Zhuoya W; Nannan Z; Aiping Z; Guoyan W; Menghua D; Jiashen Z; Yanlian X; Xiying L
    Cell Immunol; 2020 Jun; 352():104083. PubMed ID: 32143837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.